BeStock  
Stocks › Biotechnology › CGEM

Cullinan Therapeutics CGEM

US equityMarket cap rank #3236Biotechnology
$15.63 −$0.62 (-3.82%)
Pre-market · Oct 8, 8:00 am ET · After hours $15.63 0.00%
Open$15.95
Prev close$16.25
Day range$15.47 – $16.46
Volume808.2K
Market cap$1.01B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts11
Average target$35.33+126.0% vs. price
  • Buy 100%
Low $27.00Now $15.63Avg $35.33High $47.00

Recent rating changes

The last 20 actions on file set price targets from $27.00 to $42.00, averaging $36.13.

DateFirmRatingTarget
7 Oct 2026 Wedbush BUY $42.00
6 Oct 2026 Citi BUY $33.00
2 Oct 2026 William Blair BUY –
2 Oct 2026 H.C. Wainwright BUY $35.00
1 Oct 2026 BTIG BUY $40.00
25 Sep 2026 BTIG BUY $40.00
25 Sep 2026 Wedbush BUY $42.00
25 Sep 2026 H.C. Wainwright BUY $35.00
24 Sep 2026 TD Cowen BUY –
24 Sep 2026 William Blair BUY –
24 Sep 2026 BTIG BUY $40.00
24 Sep 2026 Citi BUY $33.00
15 Sep 2026 Wedbush BUY $42.00
15 Sep 2026 Morgan Stanley BUY $30.00
14 Sep 2026 William Blair BUY –
14 Sep 2026 JonesTrading BUY $36.00
14 Sep 2026 BTIG BUY $40.00
14 Sep 2026 Citi BUY $33.00
17 Aug 2026 UBS BUY $27.00
17 Aug 2026 Morgan Stanley BUY $30.00

Discussion

No comments yet — be the first to weigh in on CGEM.

Leave a comment

Scroll to Top